| Name | Title | Contact Details |
|---|
Cabinetworks Group is a prominent manufacturer and distributor of kitchen and bath cabinets in the United States. As the largest privately held cabinetmaker in the country and the second-largest overall, the company boasts a diverse portfolio of cabinetry brands, including well-known names like KraftMaid, Medallion, Schuler, and Advanta. Their products cater to a wide range of consumers and price points, ensuring options for various needs. The company serves a broad customer base, including kitchen and bath showrooms, builders, architects, and specifiers for multi-family properties. With over 8,000 employees and 18 manufacturing facilities across 24 locations, Cabinetworks Group maintains a strong presence in the market. As a portfolio company of Platinum Equity, it is committed to growth and innovation in the cabinetry sector, while also offering various career opportunities and fostering a culture of community involvement.
Everwise Credit Union puts peoples needs first, so no matter your story or your money savvy, we meet you where you are and equip you with the confidence and tools you need to get ahead—wherever youre going. Originally founded as Teachers Credit Union, helping people understand and manage their financial future has always been central to what we do, even as weve expanded our community beyond teachers. Today, we serve more than 300,000 members across nearly 60 locations in the heart of the Midwest. Through personalized resources, services, tools and unparalleled access to innovative technology, we help everyone—teenagers to retirees, business leaders to the under-served—feel more in control of their money and their future. With every interaction, we seek to fulfill our purpose of helping people grow into their dreams. ©2023 Everwise Credit Union | NMLS #686706 | Federally Insured by NCUA | Equal Housing Opportunity
Precision AQ is a global life science commercialization vendor that specializes in Health Economics and Outcomes Research (HEOR), pricing, and market access consulting for pharmaceutical and biotech companies. Headquartered in New York City, the company operates with a strong emphasis on remote work. Precision AQ is dedicated to transforming patient lives by improving access to life-changing therapies through innovative strategies and data-driven approaches. The company offers a wide range of services to support clients throughout the healthcare journey. These include research, strategy, and product development, as well as marketing, branding, and public relations. Precision AQ also focuses on generating evidence for HEOR, optimizing payer access, and facilitating investor relations. Their expertise helps clients navigate the complexities of the market and enhance their presence among healthcare professionals and patients.
Manhattan School of Music (MSM) is a renowned private music conservatory located in New York City, founded in 1917-1918 by pianist and philanthropist Janet D. Schenck. Originally established as the Neighborhood Music School in East Harlem, MSM has built a strong reputation for excellence in music education, influenced by notable artists like Pablo Casals and Harold Bauer. The school offers a range of academic programs, including Bachelor of Music, Master of Music, and Doctor of Musical Arts degrees. MSM specializes in classical and jazz performance, composition, conducting, and music education, and features a prominent opera program. Its campus in Morningside Heights includes instructional spaces, performance venues, and a residence hall, with facilities like the Hubbard Recital Hall, which houses a distinguished Aeolian-Skinner organ. MSM attracts a diverse student body of aspiring professional musicians from around the world, providing rigorous training and numerous performance opportunities. The institution is dedicated to fostering professional musicianship in both classical and jazz traditions.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.